Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Investing Activities (2016 - 2025)

Marimed (MRMD) has disclosed Cash from Investing Activities for 14 consecutive years, with -$514000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 75.8% to -$514000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.4 million, a 89.3% increase, with the full-year FY2024 number at -$17.1 million, up 34.07% from a year prior.
  • Cash from Investing Activities was -$514000.0 for Q3 2025 at Marimed, up from -$554000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$115000.0 in Q1 2025 to a low of -$16.7 million in Q2 2022.
  • A 5-year average of -$4.6 million and a median of -$4.3 million in 2024 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 501.39% in 2021, then surged 97.3% in 2025.
  • Marimed's Cash from Investing Activities stood at -$3.2 million in 2021, then rose by 21.93% to -$2.5 million in 2022, then tumbled by 152.61% to -$6.3 million in 2023, then soared by 81.1% to -$1.2 million in 2024, then skyrocketed by 57.17% to -$514000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Cash from Investing Activities are -$514000.0 (Q3 2025), -$554000.0 (Q2 2025), and -$115000.0 (Q1 2025).